Featured News
487Wire StoriesStronger Than Ever: Adani Portfolio Delivers Record Performance
45% EBITDA growth in FY24, EBITDA reaches USD 10 Bn Adani Portfolio EBITDA increased to USD 10 Bn, up by record 45%...
- 508Wire Stories
Denodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
Integration enhances the Denodo Platform, providing enterprise customers with faster, more secure, and fully scalable AI capabilities PALO ALTO, Calif.–(BUSINESS WIRE)–Denodo, a...
- 537Wire Stories
Denodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
At the office opening today, Ãngel Viña, CEO of Denodo will be joined by Dr. Shaikha Dheya Bint Ebrahim Al Khalifa and...
- 693Wire Stories
ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
DESTINY-Breast06 results show Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed medicine and antibody drug conjugate to demonstrate clinically meaningful...
- 814News
CLPð‘’ Teams Up with CityUHK to Install Solar Power System Across the Campus
HONG KONG SAR – Media OutReach Newswire – 2 June 2024 – CLPe and City University of Hong Kong (CityUHK) announced that...
- 500News
OPPO Scores Unforgettable Experiences with Global Brand Ambassador KakaÌ at the UEFA Champions League Final 2024
LONDON, UNITED KINGDOM – Media OutReach Newswire – 1 June 2024 – The UEFA Champions League final kicked off today at London’s...
- 497Wire Stories
“Experience the Luxury of Japanese Tradition and Cuisine” Reservations for the New Inbound Experience Tour in Osaka’s Tondabayashi Begin on June 1, 2024!
OSAKA, Japan–(BUSINESS WIRE)–The city of Tondabayashi in Osaka is excited to announce a new inbound tour by “SABIWabisabi,” aimed at revitalizing the...
- 513Wire Stories
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
− Four-year Analysis Conducted by GHSG Reported ADCETRIS + ECADD Combination Improved Progression-Free Survival, Showing Superior Efficacy and Tolerable Safety Profile in...
- 518Wire Stories
Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
– Differentiated Mechanism of Action of a Chimeric Degrader as Compared to Fulvestrant and Novel SERDs – – Treatment with AC699 Monotherapy...
- 4.3KFashion
Crafting Timeless Elegance: Unique Ring Designs
Welcome to our in-depth exploration of timeless elegance in unique ring designs. Whether you are a jewelry enthusiast or an engaged couple...
- 653Wire Stories
The World’s Light Painting Masters and GAC Work Together to Create a Chinese Giant Light-Painted Dragon That Shines in Dubai for the First Time
GUANGZHOU, China–(BUSINESS WIRE)–Coinciding with the Chinese Year of the Dragon in 2024, in order to celebrate the 40th anniversary of the establish...
